Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2008 2
2009 2
2010 1
2013 6
2014 3
2015 2
2016 2
2018 3
2019 3
2020 1
2021 9
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for andrej like
Your search for Andrej Likeb retrieved no results
Glucagon-like peptide-1, a matter of taste?
Jensterle M, DeVries JH, Battelino T, Battelino S, Yildiz B, Janez A. Jensterle M, et al. Rev Endocr Metab Disord. 2021 Dec;22(4):763-775. doi: 10.1007/s11154-020-09609-x. Epub 2020 Oct 29. Rev Endocr Metab Disord. 2021. PMID: 33123893 Review.
Understanding of gustatory coding helps to predict, and perhaps even modulate the ingestive decision circuitry, especially when eating behaviour becomes dysfunctional. Preclinical research demonstrated that glucagon like peptide 1 (GLP-1) is locally synthesized in taste bu …
Understanding of gustatory coding helps to predict, and perhaps even modulate the ingestive decision circuitry, especially when eating behav …
Glucagon-like peptide-1 receptor agonists in the era of COVID-19: Friend or foe?
Belančić A, Kresović A, Troskot Dijan M. Belančić A, et al. Clin Obes. 2021 Apr;11(2):e12439. doi: 10.1111/cob.12439. Epub 2021 Jan 10. Clin Obes. 2021. PMID: 33423388 Free PMC article. Review.
The aim of the present manuscript is to discuss on potential pros and cons of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as glucose-lowering agents during COVID-19 pandemic, and what is more to evaluate them as potential candidates for the treatment of patients, …
The aim of the present manuscript is to discuss on potential pros and cons of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as …
[Individualized diabetes therapy in older persons].
Zeyfang A. Zeyfang A. Internist (Berl). 2016 May;57(5):502-7. doi: 10.1007/s00108-016-0039-5. Internist (Berl). 2016. PMID: 27080251 Review. German.
Established oral therapeutic drugs, such as metformin as well as the new substance groups, such as gliptins are advantageous in this patient group. Injection-based therapies with glucagon-like peptide 1 (GLP-1) mimetics and the new insulins can also expand the spectrum of …
Established oral therapeutic drugs, such as metformin as well as the new substance groups, such as gliptins are advantageous in this patient …
Semaglutide in Obesity: Unmet Needs in Men.
Jensterle M, Rizzo M, Janež A. Jensterle M, et al. Diabetes Ther. 2023 Mar;14(3):461-465. doi: 10.1007/s13300-022-01360-7. Epub 2023 Jan 7. Diabetes Ther. 2023. PMID: 36609945 Free PMC article. No abstract available.
Auditory critical periods: a review from system's perspective.
Kral A. Kral A. Neuroscience. 2013 Sep 5;247:117-33. doi: 10.1016/j.neuroscience.2013.05.021. Epub 2013 May 21. Neuroscience. 2013. PMID: 23707979 Free article. Review.
Additional to developmental changes in synaptic plasticity, other brain functions like corticocortical interareal couplings are also influenced by deprivation. ...
Additional to developmental changes in synaptic plasticity, other brain functions like corticocortical interareal couplings are also …
Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group.
Janez A, Muzurovic E, Stoian AP, Haluzik M, Guja C, Czupryniak L, Duvnjak L, Lalic N, Tankova T, Bogdanski P, Papanas N, Nunes JS, Kempler P, Fras Z, Rizzo M. Janez A, et al. Int J Cardiol. 2022 Oct 15;365:8-18. doi: 10.1016/j.ijcard.2022.07.017. Epub 2022 Jul 26. Int J Cardiol. 2022. PMID: 35905827
Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of the endogenous GLP-1 incretin hormone, improving glycaemic control in type 2 diabetes mellitus (T2DM) by increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner. ...
Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of the endogenous GLP-1 incretin hormone, improving glycaemic cont …
45 results